Evolutionary learning-derived lncRNA signature with biomarker discovery for predicting stage of colon adenocarcinoma.
Journal:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
PMID:
40039814
Abstract
In recent years, long non-coding RNAs (lncRNAs) have emerged as potential regulators of biological processes and genes, with the potential to serve as valuable biomarkers for cancer diagnosis and prognosis prediction. This work proposes an evolutionary learning-based method, EL-COAD, to identify a robust lncRNA signature with biomarker discovery for predicting stages of colon adenocarcinoma (COAD). The COAD patient cohorts were obtained from both the Cancer Genome Atlas and Gene Expression Omnibus (gse17536) databases. EL-COAD incorporates a bi-objective combinatorial genetic algorithm with a support vector machine for selecting a minimal number of lncRNAs while maximizing prediction accuracy. EL-COAD identified a 15-lncRNA signature and achieved a five-fold cross-validation and area under receiver operating characteristic curve of 79.4% and 0.792, respectively. Utilising the 10 lncRNAs from the signature for an independent dataset gse17536, the Sequential Minimal Optimization model achieved a test accuracy of 64.15%. Furthermore, the lncRNAs of the signature were prioritized, with the top five being TMEM105, DUXAP8, APCDD1L-DT, PCAT6, and a novel transcript, ENSG00000226308. Furthermore, both Kyoto Encyclopedia of Genes and Genomes pathway and Disease Ontology analyses provided strong support for the viability of this model-independent signature, emphasising ENSG00000226308 as a promising biomarker.